April 15, 2019

On April 2, in celebration of World Autism Awareness Day, representatives from BBVA Compass Stadium, KultureCity and Texas Children’s Health Plan unveiled the Texas Children’s Health Plan Family Suite at a ribbon-cutting ceremony at the stadium.

Located in the northeast corner of the stadium outside of Section 220, the Texas Children’s Health Plan Family Suite includes a Sensory Room and a Mothers Room, making BBVA Compass Stadium the first sensory-inclusive facility in Major League Soccer. The Sensory Room was designed and installed in cooperation with KultureCity and Mothers Room at the BBVA Compass Stadium. KultureCity is the nation’s leading nonprofit dedicated to fight for inclusion and acceptance of all individuals, and advocates for those with sensory challenges such as autism and PTSD, just to name a few. It also provides training and equipment to public and private spaces in order to create an inclusive experience for everyone.

“KultureCity is truly honored to work with BBVA Compass Stadium and the Houston Dynamo to make them the first KultureCity Sensory-Inclusive MLS stadium. By recognizing this growing need and wanting to do something about it, they are truly putting their fans and guests first so that everyone regardless of their disabilities or sensory needs can be accepted and included,” said KultureCity co-founder Julian Maha, M.D. “This is a great day for the City of Houston and a great day for Major League Soccer in general. Thank you to the amazing team at the stadium and the entire Dynamo and Dash organization.”

The Mothers Room provides private space for mothers to nurse or pump while at the stadium and features seating for parent and child, as well as power outlets, a changing station and a television so mothers and children won’t miss a moment of game action.

In addition to the sensory room itself, the stadium will provide sensory bags created by KultureCity to guests who visit the space, and BBVA Compass Stadium and Houston Dynamo and Dash employees participated in sensory awareness training in order to understand how best to serve fans with unique needs and concerns.

“We take great pride in creating the most welcoming and inclusive atmosphere possible for all events at BBVA Compass Stadium, and we’re extremely excited about the addition of the Texas Children’s Health Plan Family Suite,” said Stadium Executive Vice President and General Manager Juan Rodriguez. “The Mothers Room will provide a private and comfortable space for women to care for their young children, and the Sensory Room affords fans with sensory needs the opportunity to step away if the sights and sounds inside the stadium become too much for them. We’re very grateful to the experts at KultureCity for their assistance in creating the space and training our staff.”

Since 2011, Texas Children’s Health Plan has been the official health insurance plan for Medicaid and the Children’s Health Insurance Program (CHIP) of the Houston Dynamo, Houston Dash and BBVA Compass Stadium. In addition to the new Texas Children’s Health Plan Family Suite, the health plan also sponsors the Texas Children’s Health Plan Family Section, located in Section 201 on the southwest corner of the stadium.

“We are proud to be a sponsor of the Houston Dynamo and are very excited to be part of the new Sensory Room and Mother’s Room at BBVA Compass Stadium,” Vice-President of Texas Children’s Health Plan Sherry Vetter said. “This innovative space is consistent with our mission to create a healthier future for children and women throughout our global community. The dedicated Mother’s Room gives nursing moms a private place to care for their infants while staying connected to the match and the Sensory Room provides a sensory-sensitive space for parents and children to enjoy and engage in matches on their terms.”

March 25, 2019

Dr. Richard Kellermayer, director of the Pediatric Inflammatory Bowel Disease program at Texas Children’s, has devoted much of his research to improving outcomes for children with chronic intestinal inflammation such as inflammatory bowel disease (Crohn’s disease and ulcerative colitis), as well as young patients who suffer from recurrent Clostridium difficile (C. diff) infections.

C. diff is a bacterium that causes diarrhea and inflammation of the colon, which can be severe on occasions,” said Kellermayer, associate professor of Pediatrics at Baylor College of Medicine. “Some patients are susceptible to C. diff recurrences following repeated treatment with antibiotics. It can be increasingly challenging to successfully treat these patients with conventional methods.”

In a recently published paper in the Journal of Pediatric Gastroenterology and Nutrition, Kellermayer and his colleagues provide guidelines for the safe use of fecal microbiota transplantation to treat children with recurrent C. diff infections who are unresponsive to standard antibiotic treatments. This paper resulted from the collaborative efforts of leading experts in the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPHGAN) and the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).

Texas Children’s is among few hospitals across the nation exploring fecal microbiota transplantation (FMT), a nonconventional treatment that delivers stool from healthy donors into the colon of patients with C.diff in an attempt to restore a healthy, diverse bacterial population in the gut. C. diff infection is commonly associated with the microbial imbalance created in the gut due to frequent or prolonged use of antibiotics. This lack of microbial diversity allows the bacterium to grow excessively and produce toxins that cause diarrhea and other symptoms.

FMT has been used to manage recurrent C. diff infections in adult patients, with the cure rates approaching 90 percent. While it is not fully understood how FMT works, it is believed that the transfer of stool from a healthy donor helps repopulate the recipient’s gut with many kinds of beneficial bacteria, which discourages excessive growth of C. diff.

Kellermayer along with leading experts in the field noted in the paper that the incidence of C. diff infection among hospitalized, as well as healthy children in the community, has increased dramatically in the last decade. Pediatric patients can also have recurrent infections, similar to adults while being treated with C. diff directed antibiotics.

“Repeated and prolonged use of antibiotics in children may increase their risk of developing other gastrointestinal disorders later in life,” Kellermayer said. “So, better treatment options are urgently needed to treat children with recurrent C. diff infection, and FMT seems to provide a safe and effective treatment option for these patients at present. The collaboration between our IBD program and the Texas Children’s Microbiome Center, led by Drs. James Versalovic and Tor Savidge, provides an outstanding opportunity for us to advance FMT research. We are very grateful to our benefactors led by the Wagner and Klaasmeyer families, who support our research through the Gutsy Kids Fund.”

New study underway to analyze genetic implications of complicated pediatric Crohn’s disease

In a separate study funded by the Crohn’s and Colitis Foundation, Kellermayer and his research colleagues at Texas Children’s and Baylor College of Medicine will study the genetic background of complicated pediatric Crohn’s disease, a type of chronic, inflammatory bowel disease that can affect any part of the gastrointestinal tract.

“We will conduct high-throughput, genome wide genetic analysis on patients with Crohn’s disease to see if we can find any new genes that shed light on the most aggressive forms of the disorder and what makes certain people prone to developing it,” Kellermayer said. “If we know the genetic associations, we might find new means of prevention and treatment in the future.”

Almost seven years ago, surgeons with Texas Children’s Fetal Center performed their first in-utero neural tube defect repair surgery. Just a few months ago, some of those same surgeons reached a milestone when they completed their 100th neural tube defect repair.

Of the 100 total cases, more than half were performed fetoscopically, an experimental, minimally-invasive surgical approach pioneered at Texas Children’s in 2014 by Obstetrician and Gynecologist-in-Chief Dr. Michael Belfort and Pediatric Neurosurgeon Dr. William Whitehead.

Texas Children’s was the first center in the U.S. to correct neural tube defects, also known as spina bifida defects, fetoscopically and is among just a few centers in the country that offers fetoscopic repair of spina bifida. Texas Children’s continues to offer open fetal surgery for spina bifida, the standard of care since 2012, for patients who do not qualify for or opt not to undergo a fetoscopic repair.

“This milestone shows that we are a mature program, that we have done a lot of these cases, and that our results are equivalent if not better, than anybody else out there doing this,” Belfort said. “We have a level of experience now whereby we can assure patients and families that what we offer is the best in terms of quality and safety.”

Neural tube defect repair surgeries are performed on babies with Myelomeningocele, a developmental defect in which the spine is improperly formed and the spinal cord is open to and fused with the skin. The condition, also known as spina bifida or an open neural tube defect (NTD), occurs in 3.4 out of every 10,000 live births in the U.S. and is the most common permanently disabling birth defect for which there is no known cure.

NTDs are usually associated with motor impairment and hydrocephalus, or the buildup of cerebrospinal fluid in the brain, which requires surgical treatment to drain the fluid via an implanted device called a shunt. It’s common for children with spina bifida to have abnormal function of their bladder, bowels and legs. The goal of fetal surgical repair of spina bifida is to preserve leg function and reduce the need for a postnatal shunt.

The standard of care for spina bifida is neurosurgical closure of the defect in the first days of life, however, advances in fetal surgery and the landmark clinical trial, known as the Management of Myelomeningocele Study (MOMS Trial), proved that a fetal surgical repair leads to decreased rates of hydrocephalus and improved leg function compared to a postnatal repair.

Through their research and outcomes data, Belfort and his team have shown that performing the surgery fetoscopically yields the same outcome for the baby as the open repair, while being significantly less invasive for the mother.

“We are thrilled to offer this innovative and minimally-invasive surgical approach to our patients and their babies,” Belfort said. “We thank the mothers and families who put their trust in our team and have the courage to undergo an experimental procedure.”

First fetoscopic case

The first mother to undergo fetoscopic neural tube repair at Texas Children’s Fetal Center was Althea Canezaro. At 23 weeks pregnant, Althea learned during a routine ultrasound that her son, Grayson, had spina bifida. The Louisiana resident came to Texas Children’s shortly thereafter and met with Belfort and his team.

“After talking with them, it was like, OK, there’s something they can do for us, and if it didn’t work out everyone would be safe,” Althea recalled. “We knew that this was an opportunity to give him the best life that he could have. So, going forward, it was kind of like the ball was in their park. The weight was taken off our shoulders.”

A little more than four years later, Althea and Grayson are thriving. The blonde haired, blue-eyed boy never developed hydrocephalus and was born with full movement of his legs. He is hitting all of his developmental milestones and walks with and without the assistance of crutches.

“He’s a fighter,” Althea said. “You can’t tell him he can’t do anything. He has more determination than you ever want to believe.”

Reaching a milestone

Belfort and his team performed the 100th neural tube defect repair late last year and delivered the healthy little girl, Parker Kate, on March 5. Taylor Avera, the newborn’s mother, said when she and her husband found out their child had spina bifida they were scared to death, but that what they learned at Texas Children’s put them at ease.

“Neither one of us questioned that this was what we needed to do,” Taylor said. “We were excited that we were candidates for the surgery and that we were going to be able to give our baby the best outcome she could have.”

The experimental surgery Althea and Taylor underwent continues to be subject to rigorous oversight by the U.S. Food and Drug Administration, was developed by Texas Children’s Fetal Center in partnership with Texas Children’s division of neurosurgery. The teams practiced on a child’s kickball that replicated the mother’s uterus. Inside the kickball, a doll acted as the fetus. By hoisting the ball into the air hung by various levers and pulleys, the team simulated the movement in the womb and practiced closing the spinal cord.

“The multidisciplinary collaboration with the Fetal Center on this surgical effort is an extraordinary example of the innovative spirit at Texas Children’s Hospital,” Whitehead said. “From a medical standpoint, we believe by closing the defect both in-utero and fetoscopically, is a less invasive procedure for the mother, reduces her risk of preterm delivery and reduces the need for shunts.”

View photos of both Grayson and Parker Kate below.

Texas Children’s Fetal Center is among the nation’s leaders in providing high-risk maternal care and the diagnosis and treatment of abnormalities in unborn and newborn infants. For more information, visit women.texaschildrens.org/fetal.

March 18, 2019

Just months after successfully expanding our spine surgery program outside the medical center, the Department of Surgery and Texas Children’s Hospital The Woodlands are celebrating another important milestone – the expansion of our bariatric surgery services.

“We are very pleased about the collaboration between all services in opening up the bariatric surgery program at our campus in The Woodlands,” said Surgeon-in-Chief Dr. Larry Hollier. “The Department of Surgery is committed to bringing the surgical services that families need closer to their homes.”

Previously, access to bariatric surgery was relegated to our Texas Medical Center campus. However, a review of comparative patient data and geographic analysis revealed that a large number of patients coming to Texas Children’s for bariatric surgery were coming from The Woodlands and other communities outside Houston. With support from Texas Children’s executive leadership and Department of Surgery leadership, a multidisciplinary team in The Woodlands began laying the groundwork to expand the program.

“Successfully setting up bariatric surgery in The Woodlands required extensive planning and coordination on many fronts,” said Ketrese White, assistant vice president at Texas Children’s Hospital The Woodlands. “In addition to putting necessary infrastructure in place – such as personnel, equipment and surgical space – and running simulations, this amazing team spent months mapping out optimum workflow processes, including solidifying how we identify patients and establishing a rigorous assessment plan.”

The pre-surgery assessment period for bariatric surgery is lengthy – usually six to eight months. In addition to meeting physical criteria, candidates must also undergo diagnostic testing, attend regular clinic visits, and receive lifestyle and diet education.

“We’ve been very thoughtful in developing our assessment criteria,” White said. “The team performed due diligence, reviewing best practices and consulting experts both inside and outside the Texas Children’s system, which has also helped us build relationships in the community.”

The hard work paid off. Last month, pediatric surgeon Dr. Shawn Stafford performed the first bariatric surgeries at Texas Children’s Hospital The Woodlands, the culmination of months of collaboration and preparation.

Meeting the challenge head on

The expansion of our bariatric surgery services in The Woodlands helps us meet a major need in the community. Obesity-related health problems doctors once saw only in middle-aged people are now being seen in teenagers. These conditions include high blood pressure, type 2 diabetes, polycystic ovarian syndrome, obstructive sleep apnea, severe bone and joint issues, and hepatosteatosis (fatty liver), not to mention increased risk of heart attack and cancer.

“We have a unique opportunity to intervene and head off potentially debilitating, or even fatal chronic medical conditions, and ultimately to help make a lasting difference in these kids’ lives,” Stafford said.

Because each of these cases is so different, Texas Children’s experts put special emphasis on building a program of care around each unique patients’ needs, even helping tailor an exercise regimen based on their lifestyle and interests.

“Our goal is to communicate with each patient and find things they enjoy doing so that the changes they’re making to their lifestyle will be durable,” Stafford said.

While bariatric surgery isn’t a cure for obesity, Stafford says it is a valuable tool that makes victory against obesity a possibility. But changing a lifestyle still requires effort.

“I like to describe it as if they are trying to get over a wall: I can’t make them go over, but I can give them a boost so that, if they choose, they can pull themselves over.”

Learn more about bariatric surgery at Texas Children’s.

On March 9, twelve finalist startup companies vied for awards and valuable grant funding at the fifth annual Impact Pediatric Health, a one-of-a-kind pitch competition held at SXSW that showcases the best in pediatric health care innovations. Out of 50 national and international startup applicants, the judges selected four companies to receive $25,000 grants in the Medical Devices category, provided by Southwest National Pediatric Device Consortium (SWPDC).

The four grant recipients were:

  • Bardy Diagnostics (Seattle, Washington): Develops digital health and cardiac monitoring technology
  • Prapela (Boston, Massachusetts): Uses random vibration stimulation to help newborns breathe, relax and sleep
  • PolyVascular (Houston, Texas): Designs and develops polymer-based heart valves for children that accommodate growth and reduce need for repeat surgeries
  • Smileyscope (Cambridge, Massachusetts): Transforms pediatric care delivery using virtual reality

“We were blown away by the level of talent and incredible innovation showcased at this year’s Impact Pediatric Health pitch competition,” said Dr. Chester Koh, Executive Director of SWPDC and pediatric urologist at Texas Children’s Hospital. “At Impact Pediatric Health and SWPDC, we are always looking for the next cutting-edge breakthrough in the world of medical devices, and we are excited to stand beside these four companies, and to help accelerate the next generation of medical device companies impacting our youngest of patients.”

In addition to the Medical Devices category, tech startup applicants also competed in the pediatric Digital Health and Health Disparities and Equity categories. Sound Scouts of Sydney, Australia, won top honors in Digital Health for its work developing app-based hearing assessments for school-aged children. And PolyVascular – co-founded by Dr. Henri Justino, interventional cardiologist and director of the Charles E. Mullins Cardiac Catheterization Laboratories at Texas Children’s Hospital – also received the Health Disparities and Equity award.

Winners across each category and all participants benefited from valuable feedback from a host of industry experts serving as judges at the event, including representatives from the sponsoring children’s hospitals. The panel included:

  • Molly McCarthy MBA, RN-BC, National Director of US Provider Industry and Chief Nursing Officer at Microsoft
  • Bonnie Clipper, VP, Practice and Innovation at the American Nurses Association
  • Peggy Maguire, President of Cambia Health Foundation
  • Andrew El Bardissi, Principal of Deerfield Management
  • Stacy Feld, Vice President, Consumer Venture Investments & External Innovation at Johnson & Johnson.

This year’s event was hosted by emcee, Lisa Suennen, Managing Director of Manatt Health

The Impact Pediatric Health Startup Pitch Competition was created as an opportunity for up-and-coming digital health and medical device startups to pitch their innovations to a panel of children’s hospital executives and investors during SXSW in Austin, Texas. The event is co-sponsored by Texas Children’s Hospital and six other leading U.S. children’s hospitals – Children’s Healthcare of Atlanta, Boston Children’s Hospital, Cincinnati Children’s Hospital, Children’s Hospital Los Angeles, Seattle Children’s Hospital and Lucile Packard Children’s Hospital of Stanford Children’s Health.

About SWPDC

The Southwest National Pediatric Device Consortium (SWPDC) – anchored at Texas Children’s Hospital and Baylor College of Medicine – is a multi-institutional consortium that includes clinical, scientific, business, financial, regulatory, reimbursement, engineering, intellectual property and academic partners in the Houston / Southwest U.S. region. The consortium received a five-year, $6.75 million FDA P50 Pediatric Device Consortia (PDC) grant to support innovation, mentoring and collaborations amongst pediatric clinicians and surgeons, engineers, industry, and other partners for pediatric device development.

March 11, 2019

 

Transplant Services at Texas Children’s once again led the way as the nations’ largest pediatric transplant program, performing a remarkable 107 solid organ transplants in 2018. That figure includes the highest volume of pediatric liver, lung and kidney transplants in the United States.

For the year, we performed:

  • 44 pediatric liver transplants
  • 12 lung transplants
  • 31 kidney transplants
  • 20 heart transplants

“I want to congratulate everyone on our outstanding Transplant Services team, which continues to provide excellent care and support for our transplant patients and families,” said Texas Children’s Surgeon-in-Chief Dr. Larry Hollier. “I would also like to thank the leaders of our transplant programs – Dr. John Goss, Dr. Jeffrey Heinle, Dr. Jeff Dreyer, Dr. Tina Melicoff, Dr. Daniel Leung, Dr. Christine O’Mahony, Dr. Eileen Brewer and Dr. Ryan Himes – who go above and beyond to uphold high standards.”

Transplant Services provides a comprehensive, multidisciplinary approach to care through all aspects of the transplant process, from initial referral to hospitalization and outpatient management. Our team of experts includes physicians and surgical advanced practice providers, transplant coordinators, pediatric ventricular assist device coordinators, perfusionists, child life specialists, dieticians, social workers, financial counselors, pharmacists, inpatient and outpatient nursing and support staff, Perioperative Services, physical and occupational therapists, Radiology, Pathology, our LifeGift partners, and many others.

Our depth of skill and service enables us to offer world-class care for patients, from newborns to young adults, in need of heart, kidney, liver and lung transplants. That expertise has allowed us to successfully treat some cases that other national and international programs might consider untreatable.

“This is another tremendous milestone for our program,” said Dr. John Goss, medical director of Transplant Services. “I couldn’t be prouder of our team for their commitment toward achieving positive outcomes and for the dedication they show our patients every day.”

One of those patients is Jameson Finney.

For the first 12 years of his life, Jameson was an active little boy that always moved at 100 miles an hour, his parents said. There was never the slightest indication that he might have a heart condition. On Christmas Day 2017, while opening presents with his family, Jameson suddenly became ill. Two days later, he was admitted to Texas Children’s heart failure intensive care unit and diagnosed with dilated cardiomyopathy, a condition in which the heart muscle – typically starting in the left ventricle – begins to stretch and become thin. The dilation makes the muscle unable to contract properly, which weakens the heart and can lead to heart failure.

Jameson was experiencing severe heart failure and needed life-saving surgery as soon as possible. Texas Children’s congenital heart surgeon Dr. Iki Adachi implanted a ventricular assist device on December 31, which improved Jameson’s condition so much that we was able to go home after less than a month. But his journey wasn’t over. Jameson’s best chance at survival now was a heart transplant, and he was placed on the list on March 30, 2018 – Good Friday. Less than two months later, Jameson received the miraculous gift of a new heart. Adachi, who also performed the transplant, said Jameson has been doing very well since his surgery.

Jameson’s story is just one example of the amazing work done by Transplant Services in 2018. But none of the work we do would be possible without the selfless decisions that our donor families make during the most difficult time of their lives.

“Our donor families are heroes, said Goss. “They truly give our patients a second chance at life.”

Learn more about Transplant Services at Texas Children’s.

February 25, 2019

Texas Children’s promise to provide the highest quality care to all those who come to us hasn’t changed. But Houston and the surrounding area, and the complex medical needs of our patients, are ever-changing.

To meet those needs, Promise: The Campaign for Texas Children’s Hospital was launched, with a goal of raising $475 million by 2020. The monumental fundraising effort focused on several crucial initiatives that would allow us to expand our reach in Greater Houston and beyond and to offer our world-class care to even more children who need it.

The response from the philanthropic community has defied all belief. Not only did we meet our goal, we shattered it. More than 183,000 donors raised $578.4 million – $103.4 million over the original goal – and two years ahead of schedule.

“Our plan for the largest expansion in Texas Children’s history was ambitious, but the response was extraordinary, far exceeding our wildest dreams,” said Texas Children’s President and CEO Mark Wallace. “From the very beginning, we had the support of generous philanthropists in the community, and that support remained constant – and is still absolutely vital to our success.”

Keeping our promises
  • To ensure that children who require complex care always have a place to go for treatment

Every year, more and more families come to Texas Children’s for life-saving care – care they can’t receive elsewhere. At one point, in November 2013, Texas Children’s was full and on drive-by status. Other hospitals were calling, wanting to transport their most critically ill patients, but we couldn’t accept the transports. We had to say “no.”

Texas Children’s Board of Trustees quickly approved a measure to build a new facility that would enable us to care for more children with complex conditions who require treatment that only Texas Children’s can provide.

The result – the Lester and Sue Smith Legacy Tower. The cutting-edge, 640-square-foot expansion is Texas Children’s new home for heart, intensive care and surgery, and was named for Lester and Sue Smith in honor of their transformational gift.

Before the Lester and Sue Smith Legacy Tower opened, our ICU was almost always at or over 100 percent capacity. Now the average is in the low 90 percent levels, giving us room to accept transfers of critically ill patients and to move our own patients into critical care if they need it.

  • To bring a dedicated pediatric hospital to a growing community

Just a short time ago, families from north of Houston were regularly traveling 40 miles or more to our Texas Medical Center campus with children who had chronic conditions and required ongoing treatment and management. It was too far. These families deserved the highest-quality, dedicated pediatric care close to home.

Through the overwhelming generosity of donations to the Promise Campaign, we were able to build Texas Children’s Hospital The Woodlands, which opened in May 2017. Now families living north of Houston have access to the area’s first dedicated pediatric emergency center, state-of-the-art operating rooms, world-class critical care services and an accredited motion analysis lab.

The effect in the community was felt immediately. Our first-year numbers for admissions, outpatient visits, emergency center visits, surgeries and special procedures doubled projected estimates. Moreover, expanded access in The Woodlands has freed up services at our Texas Medical Center campus for children with even more complex conditions.

  • To advance the practice and science of pediatric medicine

From its world-class neurology and cardiology departments to a comprehensive Fetal Center that is one of only a few in the world, Texas Children’s offers specialty services for children who require complex care. Philanthropic support for these programs helps bring comfort and healing to children from this community and from across the world.

The Promise Campaign raised vital funds for several of our world-class divisions and centers of excellence, such as the Jan and Dan Duncan Neurological Research Institute (NRI) and Texas Children’s Trauma and Grief Center (TAG).

Promise Campaign support for the NRI has already led to some remarkable advances, such as the identification of a likely culprit gene responsible for mild-to-severe regression of previously acquired motor and language skills. A potential link between a group of genes responsible for cellular waste-disposal disorders in children and Parkinson’s disease has also been discovered.

Texas Children’s TAG is committed to raising the standard of care and increasing access to best-practice care for traumatized and bereaved children, adolescents and their families. Generous funding through the Promise Campaign has enabled the TAG Center to expand care beyond our main campus clinic into the community to help children and families in schools, community clinics, mobile clinics and primary care pediatric offices.

  • To recruit and retain world-class physicians and scientists

Not a day goes by when one of Texas Children’s most notable experts isn’t being recruited by another leading children’s hospital. To recruit and retain world-class physicians and scientists, endowed chairs are our most powerful too.

Through the Promise Campaign, generous donors have helped Texas Children’s bring the best and brightest from across the country, including our Surgeon-in-Chief Dr. Larry Hollier, the S. Baron Hardy Chair in Plastic Surgery, and Dr. Michael Belfort, our Gynecologist-in-Chief and F.B. McGuyer Family Endowed Chair in Fetal Surgery.

Once an endowed chair is in place, the chair holder has access to significant funds that may be used to provide support for innovative research projects or to launch new programs.

  • To offer quality care to children in our community regardless of their family’s ability to pay

When Texas Children’s Hospital began in 1954, its founders made a promise that it would be a place where all children would receive the very best care, regardless of their families’ ability to pay.

That’s a promise we’re still keeping today. More than half of our patients are on Medicaid or the Children’s Health Insurance Plan. It is Texas Children’s responsibility to serve our community. Every child deserves the very best health care.

During the Promise Campaign, Texas Children’s Hospital provided an average of $13 million in charity care each year.